Cosmetic Surgery Global Market Report 2024

The cosmetic surgery market size has grown rapidly in recent years. It will grow from $48.05 billion in 2023 to $53 billion in 2024 at a compound annual growth rate (CAGR) of 10.3%. The expansion seen in the historical period can be attributed to shifts in beauty standards, the influence of celebrities, improved affordability, the impact of social media, considerations related to psychological well-being, and the pervasive influence of media and advertising in shaping consumer perceptions and choices in the beauty industry.

The cosmetic surgery market size is expected to see strong growth in the next few years. It will grow to $73.22 billion in 2028 at a compound annual growth rate (CAGR) of 8.4%. Anticipated growth in the upcoming period is expected due to the increase in non-invasive procedures, growing cultural acceptance, the aging global population, easier accessibility to information, adherence to regulatory approvals and standards, and a rising trend in male aesthetic procedures. Key trends projected for this period encompass the integration of technology into cosmetic procedures, the advancement of non-invasive procedures, the use of minimally invasive techniques, a focus on personalized and customizable procedures, the implementation of 3D imaging and simulation, and the incorporation of regenerative medicine within the field of aesthetics.

The cosmetic surgery market is experiencing growth, driven by the proliferation of cosmetic surgery hospitals. Cosmetic surgery involves procedures aimed at enhancing a person's appearance by addressing skin imperfections, wrinkles, or blemishes. Factors such as social and cultural influences from media, fashion, and the film industry, along with societal pressures for attractiveness, have contributed to the rising number of cosmetic surgery hospitals worldwide. For example, a 2021 study by the American Society of Plastic Surgeons revealed that Botox injections emerged as the most popular non-invasive cosmetic procedure in 2020, totaling 4.4 million procedures. This surge in cosmetic surgeries has led to an increase in specialized hospitals, standalone ambulatory surgical facilities, and dedicated office spaces specifically designed for conducting cosmetic procedures.

Rising disposable income is poised to drive the growth of the cosmetic surgery market. Disposable income, referring to the funds available after taxes and necessary expenses, greatly influences this market. Individuals with higher discretionary income are more capable of affording elective cosmetic procedures. For instance, data from the Bureau of Economic Analysis in August 2023 showed a slight increase of $7.3 billion (less than 0.1 percent) in disposable personal income in the US. This rise in disposable income enhances the affordability of cosmetic surgeries for individuals, thereby contributing to the growth of the cosmetic surgery market.

Product innovation stands as a significant trend gaining traction in the cosmetic surgery market. Major companies within this industry are placing emphasis on developing novel products to expand their market presence. For instance, in February 2022, Merz Aesthetics, a prominent US-based pharmaceutical company, unveiled a groundbreaking injectable implant named Radiesse (+) Lidocaine. This innovative product comprises a gel-based injectable dermal filler containing calcium hydroxylapatite (CaHa). Specifically engineered to augment volume and definition in the lower facial contours, it also focuses on tightening and lifting jowls and buccula while effectively smoothing and correcting moderate-to-severe facial wrinkles and folds. Notably, Radiesse (+) Lidocaine holds the distinction of being the first and only aesthetic injectable capable of enhancing moderate to severe loss of jawline contour, marking a significant advancement in the field.

Companies in the cosmetic surgery market are intensifying their focus on introducing cutting-edge technologies, such as laser technology, to establish a competitive edge. Laser technology involves the creation and manipulation of light via stimulated emission. For example, in June 2022, Cynosure, a renowned US-based company, unveiled the PicoSure Pro device. This device represents an advancement over the earlier PicoSure system and holds the distinction of being the first and only FDA-cleared 755nm picosecond laser available in the market. Operating at a trillionth of a second, this device utilizes pressure rather than heat to deliver energy, ensuring safe and effective treatment for unwanted pigmentation and skin revitalization across all skin types. The PicoSure Pro device offers practitioners enhanced flexibility, enabling them to cater to more patients per day and achieve superior outcomes within shorter treatment durations compared to previous models.

In December 2021, Allergan Aesthetics, an American pharmaceutical company, completed the acquisition of Soliton for an undisclosed sum. This strategic acquisition enabled Allergan Aesthetics to expand its technology portfolio by incorporating a range of non-invasive body contouring treatments, specifically targeting the appearance of cellulite. Soliton, Inc., the acquired company, specializes in medical devices, particularly in tattoo removal and cellulite reduction solutions. This acquisition empowers Allergan Aesthetics to diversify its offerings and strengthen its position in the market by incorporating innovative solutions for addressing cellulite and expanding its non-invasive body contouring treatments.

Major companies operating in the cosmetic surgery market report are Johnson & Johnson, Astellas Pharma Inc., Novartis AG, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Medtronic PLC, Polytech Health & Aesthetics GmbH, AbbVie Inc., Daiichi Sankyo Co. Ltd., Mylan N.V., Bausch Health Companies Inc., Eisai R&D Inc., Kyowa Hakko Kirin Co. Ltd., Ferring Pharmaceuticals PLC, Endo Pharmaceuticals PLC, Galderma SA, Lumenis Ltd., Solta Medical Inc., Evolus Inc., Revance Therapeutics Inc., Syneron Candela Corporation, Alma Lasers Ltd., Sinclair Pharma PLC, HansBiomed Co. Ltd., Teoxane Laboratories, Cynosure Inc., Merz Pharma GmbH & Co. KGaA, Vital Esthetique Inc., GC Aesthetics LLC, Ono Pharmaceutical Co. Ltd., Otsuka Pharmaceutical Co. Ltd., Shionogi & Co. Ltd.

North America was the largest region in the cosmetic surgery market in 2023 and is expected to be the fastest-growing region in the forecast period. The regions covered in the cosmetic surgery market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cosmetic surgery market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Cosmetic surgery encompasses three primary procedure categories such as surgical, non-surgical, and others. Surgical procedures involve invasive techniques aimed at enhancing and reshaping body structures to refine appearance. Providers offering cosmetic surgery services vary, including spas, cosmetic surgery centers, hospitals, and specialized clinics, catering to both male and female clientele. Procedures span a range from liposuction, eyelid and nose surgeries, body contouring, and face reconstruction to cosmetic implants, among others. These services are utilized by end-users such as hospitals, surgical centers, and various other entities seeking these cosmetic enhancements.

The cosmetic surgery market research report is one of a series of new reports that provides cosmetic surgery market statistics, including cosmetic surgery industry global market size, regional shares, competitors with a cosmetic surgery market share, detailed cosmetic surgery market segments, market trends and opportunities, and any further data you may need to thrive in the cosmetic surgery industry. This cosmetic surgery market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The cosmetic surgery market includes revenues earned by entities by botox, cheek lift, chemical peel, chin surgery, cosmetic dentistry, dermabrasion, eyebrow/forehead rejuvenation (brow lift) and blepharoplasty (eyelid surgery). The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.